Levin Jeremy M Insider Trades

Insider Trading History

Track insider trading activity for Levin Jeremy M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ovid Therapeutics
Ovid Therapeutics OVID
Executive Chairman
Holding Value $9.26M 3,735,048 shares
Last Trade
Mar 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$121k 47,333 shares
$2.55
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Executive Chairman
Holding Value $0 0 shares
Last Trade
Mar 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$121k 47,333 shares
$2.55
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $2.37M 957,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 957,000 shares
$1.65
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $9.15M 3,687,715 shares
Last Trade
Dec 15, 2025 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$111k 71,000 shares
$1.57
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $0 0 shares
Last Trade
Dec 15, 2025 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$111 71 shares
$1.57
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $176 71 shares
Last Trade
Dec 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$117 71 shares
$1.65
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $117k 47,333 shares
Last Trade
Dec 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$78.1k 47,333 shares
$1.65
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $88k 35,500 shares
Last Trade
Dec 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.6k 35,500 shares
$1.65
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $4.09M 1,650,000 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$941k 1,650,000 shares
$0.57
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $8.97M 3,616,715 shares
Last Trade
Mar 18, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.4k 18,248 shares
$2.76
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $1.74M 700,000 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.58M 700,000 shares
$3.68
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $10.3M 4,171,742 shares
Last Trade
Dec 04, 2023 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.83M 573,275 shares
$3.20
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $1.49M 600,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 600,000 shares
$2.50
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $1.05M 423,244 shares
Last Trade
Apr 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 423,244 shares
$3.22
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $1.49M 600,000 shares
Last Trade
Feb 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 600,000 shares
$2.72
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $1.61M 650,000 shares
Last Trade
Dec 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 650,000 shares
$2.82
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $14.4M 5,792,530 shares
Last Trade
Aug 28, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.6k 8,488 shares
$5.84
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $1.49M 600,000 shares
Last Trade
Dec 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.65M 600,000 shares
$4.42
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
10% owner, CEO
Holding Value $11.7M 4,736,529 shares
Last Trade
Oct 08, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$150k 60,000 shares
$2.50
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
CEO
Holding Value $0 0 shares
Last Trade
Sep 20, 2019 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.04M 465,116 shares
$2.24
$2.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up